CODX vs KO
Co-Diagnostics, Inc. Common Stock (CODX) versus The Coca-Cola Company (KO) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
The Coca-Cola Company (KO) is a beverages - non-alcoholic company listed on NYSE. It is led by James Quincey.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported KO revenue for 2025-12-31 was $47.94B. Net income was $13.11B. Revenue was up 1.9% from 2024-12-31 to 2025-12-31. KO currently screens at market cap $343.90B and trailing P/E 25.1.
CODX currently screens at market cap $31.4M. KO currently screens at market cap $343.90B and trailing P/E 25.1.
Not investment advice. Open the CODX and KO stock pages for the full models.
Not investment advice.